Vagus Nerve Stimulation, Side Effects, and Long-Term Safety
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Vagus nerve stimulation (VNS) is an accepted therapy for the treatment of refractory epilepsy and now even depression. More than 10,000 people have had the device implanted over a period of 12 years. Initial side effects in the early years such as lower facial weakness and electrode lead breaks have now been resolved. Postoperative infections occur in approximately 3% of patients but can be treated with oral antibiotics. Side effects during the use of VNS are usually related to the "on" phase of stimulation. Common side effects are cough, hoarseness, voice alteration, and paresthesias. These side effects tend to diminish with time. Cognitive side effects often seen with antiepileptic drug use are not reported. The side effect profile of VNS is positive, and this treatment option offers patients with refractory epilepsy prospects of good efficacy with only minor and often resolvable side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This method is also suited to applications like vagal nerve stimulation where a lack of specificity can produce significant systemic side effects [43].”
From Fascicle specific targeting for selective peripheral nerve stimulation (2019) · cites this paper as [43]
Citations
Cites
Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial
Handforth, A., DeGiorgio, C. M., Schachter, S. C., Uthman, B. M., Naritoku, D. K., Tecoma, E. S., Henry, T. R., Collins, S. D., Vaughn, B. V., Gilmartin, R. C., et al. (1998) · Neurology · doi:10.1212/wnl.51.1.48 · Cited by 1,107
Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy
Morris, G. L., Mueller, W. M., & The Vagus Nerve Stimulation Study Group E–E (1999) · Neurology · doi:10.1212/wnl.53.8.1731 · Cited by 724
Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C., Nahas, Z., Haines, S., Simpson, R. K., & Goodman, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00304-2 · Cited by 688 · cited 1×
“Apart from the indication(s) of epilepsy, there has been a small multicenter study investigating the efficacy of VNS for treatment-resistant depression (Rush et al., 2000).”
Ben‐Menachem, E., Mañon‐Espaillat, R., Ristanovic, R., Wilder, B. J., Stefan, H., Mirza, W., Tarver, W. B., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02482.x · Cited by 683 · cited 11×
“Lower facial weakness in the EO5 study occurred in two patients and in one patient in the EO3 study.”
BackgroundSelf-citationProspective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures
DeGiorgio, C. M., Schachter, S. C., Handforth, A., Salinsky, M., Thompson, J., Uthman, B., Reed, R., Collin, S., Tecoma, E., Morris, G. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00325.x · Cited by 479 · cited 2×
“These are most often easily treated with oral antibiotics and only rarely require that the generator or electrodes be excised because of this complication (DeGiorgio et al., 2000; Handforth et al., 1998; Ramsay et al., 1994).”
BackgroundVagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability
Ramsay, R. E., Uthman, B. M., Augustinsson, L. E., Upton, A. R. M., Naritoku, D., Willis, J., Treig, T., Barolat, G., Wernicke, J. F., & First International Vagus Nerve Stimulation Study Group (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02483.x · Cited by 260 · cited 1×
“These are most often easily treated with oral antibiotics and only rarely require that the generator or electrodes be excised because of this complication (DeGiorgio et al., 2000; Handforth et al., 1998; Ramsay et al., 1994).”
BackgroundAnnegers, J. F., Coan, S. P., Hauser, W. A., & Leestma, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00208.x · Cited by 253 · cited 1×
“In a comprehensive review of 1,819 patients receiving VNS, all cases of mortality associated with VNS were reported by Annegers et al. (2000).”
BackgroundEvaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years
Ben-Menachem, E., Hellström, K., Waldton, C., & Augustinsson, L. E. (1999) · Neurology · doi:10.1212/wnl.52.6.1265 · Cited by 233 · cited 2×
“There are now three long-term follow-up reports (Ben-Menachem et al., 1999; De Giorgio et al., 2000; Morris et al., 1999).”
BackgroundSelf-citationVentricular asystole during vagus nerve stimulation for epilepsy in humans
Tatum, W. O., Moore, D. B., Stecker, M. M., Baltuch, G. H., French, J. A., Ferreira, J. A., Carney, P. M., Labar, D. R., & Vale, F. L. (1999) · Neurology · doi:10.1212/wnl.52.6.1267 · Cited by 187
Cited by
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
The vagus nerve at the interface of the microbiota-gut-brain axis
Bonaz, B., Bazin, T., & Pellissier, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00049 · Cited by 1,397
“In particular, VN stimulation (VNS), approved for the treatment of depression and epilepsy (Ben-Menachem, 2001; Bonaz et al., 2013) and for its antiinflammatory properties (Borovikova et al., 2000a,b; Pavlov et al., 2003), should be of interest.”
BackgroundKoopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605635113 · Cited by 1,024
“patients receiving prior nonbiologic disease-modifying antirheumatic drugs (%) 0 drugs 1 (13) 1 (10) 2 (11) 1 drug 2 (25) 3 (30) 5 (28) 2 drugs 2 (25) 2 (20) 4 (22) 3 or more drugs 3 (37) 4 (40) 7 (39) No.”
BackgroundInfluentialReversing pathological neural activity using targeted plasticity
Engineer, N. D., Riley, J. R., Seale, J. D., Vrana, W. A., Shetake, J. A., Sudanagunta, S. P., Borland, M. S., & Kilgard, M. P. (2011) · Nature · doi:10.1038/nature09656 · Cited by 668
Chronic vagus nerve stimulation: A new and promising therapeutic approach for chronic heart failure
De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., Gavazzi, A., Sanzo, A., Dennert, R., Kuschyk, J., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq391 · Cited by 523
“More than 50 000 patients have been implanted worldwide with an acceptable sideeffect profile.(12,13,22) Although VNS for epilepsy is performed on the left cervical vagus, we stimulated the right vagus, following the previous animal experience(3,9) –11 and because the greater influence of the right-sided vagus nerve o…”
BackgroundMethod
Metadata
- Authors
- Ben-Menachem, E.
- Venue
- Journal of Clinical Neurophysiology
- Published
- 2001-09
- Volume
- 18
- Issue
- 5
- Pages
- 415-418
- ISSN
- 0736-0258 (ISSN-L)
- OpenAlex
- W1980404776
- Semantic Scholar
- 3647e2a057428c62708fdcb4412d0ec23d6d6351
- Cited by
- 400
- References
- 16
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 22 · 2023: 31 · 2022: 21 · 2021: 26 · 2020: 19 · 2019: 37 · 2018: 17 · 2017: 17 · 2016: 18 · 2015: 23 · 2014: 10 · 2013: 6 · 2012: 8
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Neurophysiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- vagus nerve stimulation, drug-resistant epilepsy, depression, adverse effects, long-term safety, facial weakness, postoperative infection, paresthesia, cognitive side effects
- MeSH terms
- Adult, Bradycardia, Child, Electrodes, Implanted, Electric Stimulation Therapy, Epilepsy, Heart Arrest, Humans, Paralysis, Spinal Cord, Time Factors, Vagus Nerve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vagus Nerve Stimulation, Side Effects, and Long-Term Safety. https://app.cochat.ai/papers/10.1097/00004691-200109000-00005
- The paper
- Ben-Menachem, E. (2001). Vagus Nerve Stimulation, Side Effects, and Long-Term Safety. Journal of Clinical Neurophysiology. https://doi.org/10.1097/00004691-200109000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.